ConditionPlacenta Accreta Spectrum
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-40
SponsorAlexandria University
About this trial
study will be carried out on patients with placenta accreta spectrum having done uterine conservation and recording immediate outcome of conservation regarding success of the procedure, amount of blood loss and amount of blood transfused and followed up to check the return of menses, any uterine abnormalities by ultrasound or hysteroscopy especially isthmocele and intrauterine synechia.
Eligibility criteria
Qualifiers
• Diagnosed sonographically to have placenta accreta spectrum.
Pregnancy is singleton and fetus is alive.
Elective caesarean section done from 35 gestational weeks.
Disqualifiers
• Patients requesting hysterectomy.
Coexisting uterine pathology such as fibroids or gynaecological malignancies.
Patients with bleeding diathesis.
Morbid obesity of BMI >40.
Trial design
Treatments tested in this trial
- closure of the uterine wall defect
- ultrasound
- outpatient hysteroscopy
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov